Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent

Circulation: Cardiovascular Imaging

Volumn 6, Issue 2, 2013, Pages 285-294

  Bhavane, Rohan ^a   Badea, Cristian ^b   Ghaghada, Ketan B ^a   Clark, Darin ^b   Vela, Deborah ^c   Moturu, Anoosha ^a   Annapragada, Akshaya ^a   Johnson, G Allan ^b   Willerson, James T ^c   Annapragada, Ananth ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TEXAS HEART INSTITUTE   (United States)

Author keywords

Atherosclerosis; Computed tomography; Contrast media; Liposome; Macrophage

Indexed keywords

APOLIPOPROTEIN E; IODINATED CONTRAST MEDIUM; IODINE DERIVATIVE; IODIXANOL; LIPOSOME; MACROGOL; CONTRAST MEDIUM; DIAGNOSTIC AGENT; IODOBENZOIC ACID DERIVATIVE; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROTIC PLAQUE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOMETRY; DRUG FORMULATION; DRUG UPTAKE; ENCAPSULATION; FEASIBILITY STUDY; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; ANIMAL; AORTA; AORTA DISEASE; AORTOGRAPHY; ATHEROSCLEROSIS; C57BL MOUSE; CELL LINE; DISEASE MODEL; EVALUATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETICS; METABOLISM; METHODOLOGY; MOUSE MUTANT; PATHOLOGY; PREDICTIVE VALUE; RADIOGRAPHY; TIME;

ANIMALS; AORTA; AORTIC DISEASES; AORTOGRAPHY; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELL LINE; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FEASIBILITY STUDIES; FLOW CYTOMETRY; LIPOSOMES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TRIIODOBENZOIC ACIDS;

MLCS; MLOWN;

EID: 84877309415     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.112.000119     Document Type: Article

References (46)

1. Hansson G. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
2. Duff G. The pathogenesis of atherosclerosis. Can Med Assoc J. 1951;64:387-394.
3. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the unstable plaque. Prog Cardiovasc Dis. 2002;44:349-356.
4. Virmani R, Narula J, Leon M, Willerson J. The Vulnerable Atherosclerotic Plaque: Strategies for Diagnosis and Management. John Wiley & Sons Ltd; 2007.
5. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
6. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003;108:1664-1672.
7. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;47(8 suppl):C13-C18.
8. Johnson LL, Schofield L, Donahay T, Narula N, Narula J. 99mTc-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries. J Nucl Med. 2005;46:1186-1193.
9. Nahrendorf M, Keliher E, Panizzi P, Zhang H, Hembrador S, Figueiredo JL, Aikawa E, Kelly K, Libby P, Weissleder R. 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. JACC Cardiovasc Imaging. 2009;2:1213-1222.
10. Chen J, Tung CH, Mahmood U, Ntziachristos V, Gyurko R, Fishman MC, Huang PL, Weissleder R. In vivo imaging of proteolytic activity in atherosclerosis. Circulation. 2002;105:2766-2771.
11. Botnar RM, Perez AS, Witte S, Wiethoff AJ, Laredo J, Hamilton J, Quist W, Parsons EC Jr, Vaidya A, Kolodziej A, Barrett JA, Graham PB, Weisskoff RM, Manning WJ, Johnstone MT. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation. 2004;109:2023-2029.
12. Hyafil F, Cornily JC, Feig JE, Gordon R, Vucic E, Amirbekian V, Fisher EA, Fuster V, Feldman LJ, Fayad ZA. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med. 2007;13:636-641.
13. Nahrendorf M, Zhang H, Hembrador S, Panizzi P, Sosnovik DE, Aikawa E, Libby P, Swirski FK, Weissleder R. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation. 2008;117:379-387.
14. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation. 2001;103:415-422.
15. Litovsky S, Madjid M, Zarrabi A, Casscells SW, Willerson JT, Naghavi M. Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma. Circulation. 2003;107:1545-1549.
16. Cormode DP, Roessl E, Thran A, Skajaa T, Gordon RE, Schlomka JP, Fuster V, Fisher EA, Mulder WJ, Proksa R, Fayad ZA. Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology. 2010;256:774-782.
17. Hyafil F, Cornily JC, Rudd JH, Machac J, Feldman LJ, Fayad ZA. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology. J Nucl Med. 2009;50:959-965.
18. Alberts DS, Muggia FM, Carmichael J, Winer EP, Jahanzeb M, Venook AP, Skubitz KM, Rivera E, Sparano JA, DiBella NJ, Stewart SJ, Kavanagh JJ, Gabizon AA. Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials. Semin Oncol. 2004;31(suppl 13):53-90.
19. Mukundan S Jr, Ghaghada KB, Badea CT, Kao CY, Hedlund LW, Provenzale JM, Johnson GA, Chen E, Bellamkonda RV, Annapragada A. A liposomal nanoscale contrast agent for preclinical CT in mice. AJR Am J Roentgenol. 2006;186:300-307.
20. Samei E, Saunders RS, Badea CT, Ghaghada KB, Hedlund LW, Qi Y, Yuan H, Bentley RC, Mukundan S Jr. Micro-CT imaging of breast tumors in rodents using a liposomal, nanoparticle contrast agent. Int J Nanomedicine. 2009;4:277-282.
21. Johnston SM, Johnson GA, Badea CT. Geometric calibration for a dual tube/detector micro-CT system. Med Phys. 2008;35:1820-1829.
22. Badea C, Hedlund LW, Johnson GA. Micro-CT with respiratory and cardiac gating. Med Phys. 2004;31:3324-3329.
23. Sun Z, Cao Y. Multislice CT angiography assessment of left coronary artery: correlation between bifurcation angle and dimensions and development of coronary artery disease. Eur J Radiol. 2011;79:e90-e95.
24. Feldkamp L, Davis L, Kress J. Practical cone-beam algorithm. J Opt Soc Am. 1984;1:612-619.
25. Badea C, Johnston S, Qi Y, Ghaghada K, Johnson G. Dual-energy micro- CT imaging for differentiation of iodine- and gold-based nanoparticles. Paper presented at: Progress in Biomedical Optics and Imaging - Proceedings of SPIE 7961; 2011; Lake Buena Vista, FL.
26. Clark D, Johnson GA, Badea CT. Denoising of 4D cardiac micro-CT data using median-centric bilateral filtration. Proc SPIE. 2012:8314: 83143Z.
27. Ghaghada K, Hawley C, Kawaji K, Annapragada A, Mukundan S Jr. T1 relaxivity of core-encapsulated gadolinium liposomal contrast agents - effect of liposome size and internal gadolinium concentration. Acta Radiol. 2008;15:1259-1263.
28. Narula J, Garg P, Achenbach S, Motoyama S, Virmani R, Strauss HW. Arithmetic of vulnerable plaques for noninvasive imaging. Nat Clin Pract Cardiovasc Med. 2008;(suppl 2):S2-10.
29. van Oostrom O, Velema E, Schoneveld AH, de Vries JP, de Bruin P, Seldenrijk CA, de Kleijn DP, Busser E, Moll FL, Verheijen JH, Virmani R, Pasterkamp G. Age-related changes in plaque composition: a study in patients suffering from carotid artery stenosis. Cardiovasc Pathol. 2005;14:126-134.
30. Madjid M, Vela D, Khalili-Tabrizi H, Casscells SW, Litovsky S. Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes. Tex Heart Inst J. 2007;34:11-18.
31. Folco EJ, Sheikine Y, Rocha VZ, Christen T, Shvartz E, Sukhova GK, Di Carli MF, Libby P. Hypoxia but not inflammation augments glucose uptake in human macrophages: implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography. J Am Coll Cardiol. 2011;58:603-614.
32. Primak AN, Giraldo JC, Eusemann CD, Schmidt B, Kantor B, Fletcher JG, McCollough CH. Dual-source dual-energy CT with additional tin filtration: dose and image quality evaluation in phantoms and in vivo. AJR Am J Roentgenol. 2010;195:1164-1174.
33. Ranson MR, Carmichael J, O'Byrne K, Stewart S, Smith D, Howell A. Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial. J Clin Oncol. 1997;15:3185-3191.
34. Burke SJ, Annapragada A, Hoffman EA, Chen E, Ghaghada KB, Sieren J, van Beek EJ. Imaging of pulmonary embolism and t-PA therapy effects using MDCT and liposomal iohexol blood pool agent: preliminary results in a rabbit model. Acad Radiol. 2007;14:355-362.
35. Ghaghada KB, Bockhorst KH, Mukundan S Jr, Annapragada AV, Narayana PA. High-resolution vascular imaging of the rat spine using liposomal blood pool MR agent. AJNR Am J Neuroradiol. 2007;28:48-53.
36. Ghaghada KB, Badea CT, Karumbaiah L, Fettig N, Bellamkonda RV, Johnson GA, Annapragada A. Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging. Acad Radiol. 2011;18:20-30.
37. Chono S, Tauchi Y, Morimoto K. Pharmacokinetic analysis of the uptake of liposomes by macrophages and foam cells in vitro and their distribution to atherosclerotic lesions in mice. Drug Metab Pharmacokinet. 2006;21:37-44.
38. Pan D, Williams TA, Senpan A, Allen JS, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM. Detecting vascular biosignatures with a colloidal, radioopaque polymeric nanoparticle. J Am Chem Soc. 2009;131:15522-15527.
39. Rabin O, Manuel Perez J, Grimm J, Wojtkiewicz G, Weissleder R. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater. 2006;5:118-122.
40. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994;14:133-140.
41. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, Figueiredo JL, Kohler RH, Chudnovskiy A, Waterman P, Aikawa E, Mempel TR, Libby P, Weissleder R, Pittet MJ. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009;325:612-616.
42. Jawień J, Nastałek P, Korbut R. Mouse models of experimental atherosclerosis. J Physiol Pharmacol. 2004;55:503-517.
43. Badimon L, Vilahur G, Padro T. Atherosclerosis and thrombosis: insights from large animal models. J Bioenerg Biomembr. 2011.
44. Szebeni J. The interaction of liposomes with the complement system. Crit Rev Ther Drug Carrier Syst. 1998;15:57-88.
45. Cassetta L, Cassol E, Poli G. Macrophage polarization in health and disease. ScientificWorldJournal. 2011;11:2391-2402.
46. Zeyda M, Stulnig TM. Adipose tissue macrophages. Immunol Lett. 2007;112:61-67.